Controversy swirls around adipose-derived cell therapies for reparative medicine
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, February 19, 2020--Challenging the U.S. Food and Drug Administration's current approach to evaluating and approving adipose-based...
















